Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

IL17RA

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

Interleukin 17 receptor A (IL17RA) is the first discovered member of the interleukin 17 receptor family, and it also serves as a shared signaling subunit in several IL-17 receptor complexes. Its contribution depends on the specific receptor complex and ligand context rather than applying uniformly to every IL-17 family cytokine. It is a single-pass transmembrane protein, which means the entire protein only crosses the cell membrane once. The extracellular portion of the protein is constructed from III type fibronectin domains, while the intracellular tail segment contains a SEFIR domain conserved across the IL-17 receptor family. This domain can recruit pathway-specific adaptor proteins to initiate inflammation-related transcription programs, eliminating the need for most cytokine receptors to rely on common classic signaling adaptor proteins; it follows its own independent signaling pathway. All physiological activities transmitted through this intersection form the core foundation of barrier immunity. What is barrier immunity? It is the immune line of defense that the body uses to block invasion by external microorganisms and protect the integrity of the body's surfaces and cavities. IL-17 signaling prompts epithelial and stromal tissues such as those in the skin, intestines, lungs, and joints to produce antimicrobial defense substances and inflammatory mediators, which also makes IL17RA a key node in the core axis that protects the body's surfaces from microbial invasion. The entire defense line's ability to function relies entirely on this node to hold it up. Its biological role is so critical that it also brings non-negligible side effects: if this pathway, originally tasked with safeguarding the integrity of barrier tissues, remains in a sustained activated state and works continuously without rest, it will instead trigger inflammation that damages the body's own tissues. This is a typical characteristic seen in all types of autoimmune and inflammatory research: a pathway originally meant to protect the body turns into the main culprit that harms the body.

Fig. The IL17R mediated transcriptional and posttranscriptional changes in target cells. (OA Literature)Fig.1 Interleukin-17 signaling.1

IL17RA in Action: A Shared Gateway with Unconventional Wiring

Research on IL17RA continues to deepen along several interconnected lines:

  • The Shared-Chain Recognition Logic: Unlike receptors with dedicated ligand pairs, IL17RA acts as a universal docking element, combining with different partner subunits to receive distinct IL-17 family members. This modular partnership strategy concentrates signaling diversity into a single gateway—and makes the receptor an instructive case study in how shared recognition architecture can serve multiple ligands.
  • The Dedicated Adaptor Pathway: Cytoplasmic signaling through IL17RA bypasses classical cytokine adaptors entirely, relying instead on a specialized docking motif that recruits a pathway-specific adaptor to inflammatory transcriptional programs. This unconventional wiring has made the receptor a reference point for understanding how nature invents new signaling solutions outside established frameworks.
  • Barrier Defense and Inflammatory Balance: Through epithelial and stromal responses, IL17RA-dependent signaling arms body-surface tissues against microbial challenge while setting the inflammatory tone of those same environments. The pathway's dual capacity for protection and damage places the receptor at the center of research programs probing how barrier immunity is calibrated.

IL17RA Membrane Protein Product List

Our IL17RA membrane protein portfolio is grounded in a clear conviction: a shared gateway receptor can only be studied with confidence when its modular architecture survives preparation intact. IL17RA's fibronectin type III extracellular domains must fold correctly to present ligand-recognition surfaces, and its single-pass anchor must support native orientation for partner-chain engagement and adaptor recruitment. Accordingly, we deliver full-length IL17RA preparations produced in optimized eukaryotic expression systems engineered to preserve these exacting features. Every production lot is verified across multiple quality attributes: purity assessed by SDS-PAGE, monodispersity by analytical size-exclusion chromatography.

IL17RA Protein Product

Not finding the membrane protein product you need? Contact us to start your one-stop custom service!

IL17RA Stable Cell Line Product List

Cellular platforms for IL17RA research must combine controlled receptor density with faithful surface presentation and adaptor-pathway signaling competence, because the receptor's meaning lies in how it assembles with partners and transduces cytokine—not merely in how much of it is expressed. We provide customized, high-expressing IL17RA stable cell lines developed through sequence-optimized stable integration, ensuring sustained, uniform receptor presentation within reproducible backgrounds. Our products spans lines stably wild-type IL17RA and variants carrying engineered substitutions for diverse investigation. Each clone is released only after exhaustive phenotypic verification.

IL17RA Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

IL17RA Recombinant Antibody Product List

To advance your IL17RA research project, you may try our validated recombinant antibody portfolio. This set of antibodies is purpose-designed to maintain stable detection specificity in all analytical and functional experiments commonly used in cytokine receptor research, deliver accurate and repeatable quantitative results, and meet the experimental needs of various research projects. These high-affinity monoclonal and recombinant antibody clones are all generated against specific epitopes, and can stably and specifically recognize IL17RA under various experimental conditions without misidentifying other proteins, ensuring the basic reliability of experiments. Every antibody clone has undergone complete sequence verification, and all are produced from a fixed recombinant expression construct, completely eliminating performance variability between batches. Even for long-term research spanning several years, using different batches of the same antibody can guarantee the consistency of results, so that fluctuations in reagents will not affect experimental conclusions. Its scope of validation covers all the most common experimental scenarios for IL17RA researchers. No matter what type of experiment you plan to conduct, this set of antibodies can be adapted, eliminating the need to spend time validating the usability of antibodies yourself.

IL17RA Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • High Purity & Activity: High purity and verified integrity for dependable downstream work.
  • Diverse Expression Systems: Choice of expression formats to match routine or specialized projects.
  • Species Reactivity: Products available for human, mouse, pig, and other species.
  • Validated Applications: Application-tested to deliver consistent signals across common lab workflows.
  • Exceptional Lot-to-Lot Consistency: Tight lot-to-lot control for reproducible performance.
  • Customization Options: Flexible customization of tags, labels, or packaging upon request.

Custom IL17RA Membrane Protein and Antibody Discovery Services

Extending well beyond our standard catalog, we deliver fully customizable discovery and manufacturing solutions meticulously tailored to the sophisticated demands of IL17RA-targeted research and compound development:

  • Custom IL17RA Protein Production: Tailored expression, purification, and characterization of challenging multi-domain receptor constructs.
  • Custom Antibody Development: From antigen design to antibody engineering (monoclonal, polyclonal, recombinant) for specific research applications.
  • Stable Cell Line Development: Generation of bespoke stable cell lines expressing your target of interest.
  • Functional Assay Development: Designing and executing assays to assess receptor activation and ligand.

Frequently Asked Questions (FAQ)

  1. What details are most helpful to include in a first inquiry?

    A concise description of your application, the format you envision, and any acceptance criteria you already hold is enough. Our team will help refine the technical specifics from there.

  2. Can special formats or multi-component projects be accommodated?

    Yes. Custom format requests and integrated engagements spanning protein, cell line, and antibody needs are routine for us and are managed under unified quality frameworks.

  3. What is the intended use scope of these reagents and services?

    All IL17RA products and services are provided strictly for preclinical research. They are not designed, validated, or authorized for any use involving human subjects.

  4. How do I decide whether a catalog product or custom service fits my needs?

    Catalog items serve routine detection and binding workflows well. Custom arrangements earn their keep when constructs, formats, or quality attributes go beyond standard specifications. A brief consultation typically settles the question quickly.

Reference
  1. Ladjevac, Nevena, et al. "The role of IL-17 in the pathogenesis of oral squamous cell carcinoma." International Journal of Molecular Sciences 24.12 (2023): 9874. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms24129874
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;